Artificial Heart and Ventricular Assist Devices Market By Product and Service, By Application, By End User and Region: Global Industry Analysis, Share, Opportunity, Competition and Forecast 2021 to 2027 - SynCardia Systems, Medtronic PLC, Abbott Laborator

The “Artificial Heart and Ventricular Assist Devices Market” report provides 2021-2027 a detailed market overview based on current and future trends that will determine the profit structure. Market size, demand, supply chain, market growth factors, and future trends. It involves an in-depth study of the current trends leading to this vertical trend in different regions. The report provides important information related to components and factors such as market size, market share, market segmentation, main growth drivers, and market competition. Artificial Heart and Ventricular Assist Devices market segments are highlighted by type and application, region, and major players. It provides key statistics on the market conditions of major market participants.

“The Artificial Heart and Ventricular Assist Devices Market is predicted to register a CAGR of 18% over the forecast period 2021 – 2027.”

Get a Sample Link of this Report:

https://www.marketintelligencedata.com/reports/524498/global-artificial-heart-and-ventricular-assist-devices-market-research-report-2021/inquiry?Mode=rukaiyya

Market Overview:

Some of the major factors anticipated to drive the demand for Ventricular Assist Devices (VADs) include the growing global geriatric population suffering from the rising prevalence of chronic disorders like diabetes, neurological disorders, cardiovascular diseases, hypertension, and stroke. Rapid globalization coupled with the pursual of unhealthy lifestyles in both developed and developing nations is contributing to the growing risk of chronic ailments. The growing prevalence of cardiovascular diseases is, in turn, expected to drive the demand for ventricular assist devices. Moreover, these diseases increase the risk of organ failure and due to the deficiency of organ donors and delay in organ transplantations, the demand for VADs is expected to rise over the forthcoming years.

Key Competitors of the Artificial Heart and Ventricular Assist Devices market is:

SynCardia Systems, Medtronic PLC, Abbott Laboratories, BiVACOR, Berlin Heart, ABIOMED, LivaNova PLC, CARMAT, Jarvik Heart Inc, Chongqing Yongrenxin Medical, Thoratec, Cleveland Heart, CryoLife

Recent Development

Abbott Laboratories 

Abbott Laboratories has acquired 36 companies, including 5 in the last 5 years. A total of 9 acquisitions came from private equity firms. It has also divested 8 assets. Abbott Laboratories’ largest acquisition to date was in 2016 when it acquired St. Jude Medical for $25.0B. Its largest disclosed sale occurred in 2015 when it sold Abbott - Non-U.S. Developed Markets Specialty and Branded Generics to Viatris for $5.3B. Abbott Laboratories has acquired in 8 different US states, and 9 countries. The Company’s most targeted sectors include medical products (55%) and life science (34%).

CryoLife

CryoLife has acquired 8 companies, including 3 in the last 5 years. It has also divested 4 assets. CryoLife’s largest acquisition to date was in 2017 when it acquired JOTEC for $225M. Its largest disclosed sale occurred in 2021 when it sold CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets to Baxter International for $61M. CryoLife has been acquired in 5 different US states, and 3 countries. The Company’s most targeted sectors include medical products (100%).

Impact of COVID-19 on the Artificial Heart and Ventricular Assist Devices Market:

The rise of COVID-19 has tempered showcase improvement; anyhow, the market is consistently choosing up-tempo because of growing lockdowns. The fast increment in CAGR is thanks to the request and extension of this marketplace, which is a practicality to come to pre-pandemic ranges once the large, is gone.

Major Types covered are:

Artificial Heart
Ventricular Assist Devices

Major Applications covered are:

Coronary Heart Disease
Cerebrovascular Disease
Peripheral Arterial Disease
Rheumatic Heart Disease
Congenital Heart Disease
Deep Vein Thrombosis
Other

To Get Report Link:

https://www.marketintelligencedata.com/reports/524498/global-artificial-heart-and-ventricular-assist-devices-market-research-report-2021?Mode=rukaiyya

will get up-to-date with you within 24hrs and assist you to notice the analysis reports and extra Customization you need.

North America Dominates the Artificial Heart and Ventricular Assist Devices Market

The North American region is among the major contributor in this market due to the advancements in technology, and the increasing burden of heart diseases. According to the Centers for Disease Control and Prevention (CDC), about 647,000 Americans die from heart disease each year. The increasing number of individuals with heart diseases leads to higher demand. Over 30% of global LVAD implants are being performed in the United States, and the number of implants is increasing year by year. Hence, the high adoption rate for these devices is expected to increase the cardiac assist devices market significantly during the forecast.

Regional market Artificial Heart and Ventricular Assist Devices (regional production, demand and forecast by country):

South America (Brazil, Argentina, Ecuador, Chile)

Asia Pacific (China, Japan, India, Korea)

Europe (Germany, UK, France, Italy)

Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) And more.

The inquire approximately record considers the past, display, and destiny execution of the global market. The record advances investigations the display aggressive situations, most important trade models, and consequently the possible headways in services with the aid of using crucial gamers inside the upcoming years.

Buy Report Here:

https://www.marketintelligencedata.com/report/purchase/524498?mode=su?Mode=rukaiyya

Report Features:

To project the value and sales volume of the Artificial Heart and Ventricular Assist Devices market, concerning key regions.
To analyses competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To study and analyses the global Artificial Heart and Ventricular Assist Devices market size (value & volume) by company, key regions, products, and end-user, breakdown data from The Last Five Years, and forecast to 2027.
To understand the structure of the Artificial Heart and Ventricular Assist Devices market by identifying its various sub-segments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, industry-specific challenges, and risks).

Report Customization:

The Global Artificial Heart and Ventricular Assist Devices Market report may be modified to meet your specific business needs. Because we understand what our clients want, we offer 25% customization for any of our MarketIntelligenceData reports at no additional cost to all or any of our clients.

About Us:

Market intelligence data is a global front-runner in the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

Contact Us:

Irfan Tamboli (Head of Sales) – MARKET INTELLIGENCE DATA

Phone: +1 (704) 266-3234

Mail to: sales@marketintelligencedata.com   

This release was published on openPR.